Canadian Medical Association journal

Published by Canadian Medical Association
Online ISSN: 0008-4409
Publications
Article
Our current state of schools has caused much dissention in the academic world. Everyone has a stake in the fight and of course the social education field is no different. We have an extensive laundry list of issues and concerns that are destroying public education. Teachers are deskilled, students are indoctrinated with isolated facts that allow for no actual analysis and schools are continually under attack by policies counterintuitive educational goals (Friere, 1993; Giroux, 2003). Unfortunately this negative perception of the academic world has since become the singular lens distorting my own personal view of what’s going on in the classrooms. I wind up expending a great deal of energy looking for what is missing.
 
Article
Norethindrone 5 mg. plus mestranol 0.075 mg., taken daily from menstrual cycle day five through day 24, was used as an oral contraceptive agent in 1248 cycles by 132 clinic patients. One hundred and one patients used this method for six months or more. There were no unplanned pregnancies. Breakthrough bleeding occurred in 38 cycles (3.0% of all cycles). In 25% of 1201 cycles the duration of menstrual flow was shorter than that which had been considered usual for the individual patient involved, and the most common weight change was a gain of 6 to 10 lb.
 
Article
Norethindrone 2 mg. with mestranol 0.1 mg. (Ortho-Novum 2 mg.) was taken in cyclic fashion for fertility control by 62 private patients through 312 cycles. Each patient was interviewed every month during the trial period. No pregnancies occurred. The most common side effects noted were breakthrough bleeding, headache, fatigue and tension, nausea and depression. Five patients left the study because of depression and one because of nausea. It is suggested that the use of norethindrone 2 mg. with mestranol 0.1 mg. be reserved for the following situations: (1) those patients who have used other methods without success and in whom a further pregnancy would, in the opinion of the family physician, create hardship; (2) those patients in whom fear of pregnancy is part of the cause of marital problems; and (3) those patients in whom the product is primarily used for the treatment of menstrual disorders.
 
Top-cited authors
Stewart O Pugsley
  • McMaster University
Penelope Thompson
  • McMaster University
Roy Shephard
  • University of Toronto
Richard Melzack
Stephanie Valberg
  • Michigan State University